Source:http://linkedlifedata.com/resource/pubmed/id/12405288
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2002-10-30
|
pubmed:abstractText |
Activation of matrix metalloproteinase-2 (MMP-2) is a common event in head and neck squamous cell carcinoma. An OSC-19 cell line, derived from human oral squamous cell carcinoma and known to metastasize to cervical lymph nodes, was implanted into the lingual margin of mice. The effect of marimastat (BB-2516), a broad MMP inhibitor, on the suppression of regional cervical lymph node metastasis was evaluated with an orthotopic implantation nude mice model. Marimastat was given immediately after OSC-19 implantation and continuously administered by an osmotic pump. The mice were divided into three groups by marimastat dose; Group A; 0 mg/kg/day, Group B; 30 mg/kg/day, and Group C; 150 mg/kg/day. Twenty-one days after implantation, primary oral tumors and cervical lymph nodes were resected. Cervical lymph node status was microscopically examined. Activation of MMP-2 in primary oral tumor was examined by gelatin zymography. Both cervical lymph node metastasis and activation of MMP-2 were significantly suppressed in Group C (P < 0.05). Moreover, the Group C mice had a significantly better survival than group A (P = 0.0026). There was a significant difference between Group A and Group C in terms of proliferation of tumor cells by proliferating cell nuclear antigen immunostaining (P = 0.0120). These results suggest a positive role for marimastat in the inhibition of MMP-2 activation and prevention of cervical lymph node metastasis in oral squamous cell carcinoma (OSCC). Improvement of survival in patients with OSCC could be expected using adjuvant therapy with marimastat.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxamic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 2,
http://linkedlifedata.com/resource/pubmed/chemical/marimastat
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0262-0898
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
513-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12405288-Animals,
pubmed-meshheading:12405288-Antineoplastic Agents,
pubmed-meshheading:12405288-Carcinoma, Squamous Cell,
pubmed-meshheading:12405288-Cell Division,
pubmed-meshheading:12405288-Enzyme Inhibitors,
pubmed-meshheading:12405288-Humans,
pubmed-meshheading:12405288-Hydroxamic Acids,
pubmed-meshheading:12405288-Lymphatic Metastasis,
pubmed-meshheading:12405288-Male,
pubmed-meshheading:12405288-Matrix Metalloproteinase 2,
pubmed-meshheading:12405288-Mice,
pubmed-meshheading:12405288-Mice, Nude,
pubmed-meshheading:12405288-Mouth Neoplasms,
pubmed-meshheading:12405288-Time Factors,
pubmed-meshheading:12405288-Transplantation, Heterologous
|
pubmed:year |
2002
|
pubmed:articleTitle |
Inhibition of cervical lymph node metastasis by marimastat (BB-2516) in an orthotopic oral squamous cell carcinoma implantation model.
|
pubmed:affiliation |
Department of Otolaryngology, School of Medicine, Kanazawa University, Japan.
|
pubmed:publicationType |
Journal Article
|